De Witte Jan 4/A
4/A · RESMED INC · Filed May 22, 2024
Insider Transaction Report
Form 4/AAmended
RESMED INCRMD
De Witte Jan
Director
Transactions
- Sale
ReMed Common Stock
2024-05-15$218.29/sh−360$78,584→ 7,519 total
Footnotes (1)
- [F1]Amended to indicate that the transaction was conducted under a Rule 10b5-1 plan adopted February 2, 2024.